Erythropoietin as an antiapoptotic, tissue-protective cytokine
The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Abstract
Erythropoietin (EPO) increases the number of circulating erythrocytes primarily by preventing apoptosis of erythroid progenitors. In addition to this proerythroid action, results of recent studies show that systemically administered EPO is protective in vivo, in several animal models of neuronal injury. In vitro, EPO prevents neuronal apoptosis induced by a variety of stimuli. This review summarizes the neuroprotective actions of EPO and discusses the underlying mechanisms in terms of signal transduction pathways involved. The understanding of these mechanisms will help differentiate the neuroprotective actions of EPO from its role in the bone marrow.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Erythropoietin was originally recognized via its role in erythropoiesis [2145-2147] (hence its name, of course), but it has become evident that it has many other roles, and in particular it is observed phenomenologically that erythropoietin (and non-erthyropoetic derivatives) is protective in a number of inflammatory conditions that accompany many diseases such as those listed above [940,942,2148-”
From Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases (2009) · cites this paper as [2149]
Citations
Cites
Structural design and molecular evolution of a cytokine receptor superfamily.
Bazan, J. F. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.18.6934 · Cited by 2,069 · cited 1×
“cytokines of the IL-6 family (IL-6, leukemia inhibitory factor (LIF), ciliary neurotrophic factor (CNTF) and oncostatin M).(21,22)”
BackgroundNF-κB is a target of AKT in anti-apoptotic PDGF signalling
Romashkova, J. A., & Makarov, S. S. (1999) · Nature · doi:10.1038/43474 · Cited by 1,517
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
Brines, M. L., Ghezzi, P., Keenan, S., Agnello, D., de Lanerolle, N. C., Cerami, C., Itri, L. M., & Cerami, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.19.10526 · Cited by 1,402
Self-citationVEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia
Sun, Y., Jin, K., Xie, L., Childs, J., Mao, X. O., Logvinova, A. V., & Greenberg, D. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17977 · Cited by 1,282
HIF-1 and mechanisms of hypoxia sensing
Semenza, G. L. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00194-0 · Cited by 1,268
VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia
Sun, Y., Jin, K., Xie, L., Childs, J., Mao, X. O., Logvinova, A., & Greenberg, D. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317977 · Cited by 1,189
Wenger, R. H. (2002) · The FASEB Journal · doi:10.1096/fj.01-0944rev · Cited by 1,135 · cited 1×
“been suggested that, because HIF is often constitutively expressed in tumors, it may mediate the high constitutive expression of glycolytic enzymes that is the basis of the Warburg effect.(3,5)”
BackgroundErythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial
Ehrenreich, H., Hasselblatt, M., Dembowski, C., Cepek, L., Lewczuk, P., Stiefel, M., Rustenbeck, H.-H., Breiter, N., Jacob, S., Knerlich, F., et al. (2002) · Molecular Medicine · doi:10.1007/bf03402029 · Cited by 1,028 · cited 1×
“of human stroke by EPO used three daily doses substantially higher than the clinical norm and, in these patients, EPO was shown to be safe and did not raise the hemoglobin concentration.(80) Thus, this might represent a valuable therapeutic approach to acute CNS injury, such as brain and spinal cord trauma.”
Self-citationErythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
Sirén, A.-L., Fratelli, M., Brines, M., Goemans, C., Casagrande, S., Lewczuk, P., Keenan, S., Gleiter, C., Pasquali, C., Capobianco, A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051606598 · Cited by 1,019 · cited 3×
“Using a model of ischemia with reperfusion, it was shown that neurons within the penumbra would undergo apoptosis unless exposed to EPO within 3 h of injury.(39) In addition to this antiapoptotic effect, EPO administration is also associated with a marked decrease in proinflammatory cytokines within the hemisphere und…”
BackgroundMethodInfluentialSelf-citationOosthuyse, B., Moons, L., Storkebaum, E., Beck, H., Nuyens, D., Brusselmans, K., Dorpe, J. V., Hellings, P., Gorselink, M., Heymans, S., et al. (2001) · Nature Genetics · doi:10.1038/88842 · Cited by 1,007
Cited by
Items 101–200 of 336
Sifringer, M., Genz, K., Brait, D., Brehmer, F., Löber, R., Weichelt, U., Kaindl, A. M., Gerstner, B., & Felderhoff‐Mueser, U. (2009) · Developmental Neuroscience · doi:10.1159/000232557 · Cited by 42
Protecting Mitochondrial Bioenergetic Function During Resuscitation from Cardiac Arrest
Gazmuri, R. J., & Radhakrishnan, J. (2012) · Critical Care Clinics · doi:10.1016/j.ccc.2012.02.001 · Cited by 45
Chang, Y., Choi, D. E., Na, K. R., Lee, S.-J., Suh, K., Kim, S. Y., Shin, Y.-T., & Lee, K. W. (2009) · The Journal of Urology · doi:10.1016/j.juro.2008.10.105 · Cited by 38
Erythropoietin-activated mesenchymal stem cells promote healing ulcers by improving microenvironment
Lu, H., Wu, X., Wang, Z., Li, L., Chen, W., Yang, M., Huo, D., Zeng, W., & Zhu, C. (2016) · Journal of Surgical Research · doi:10.1016/j.jss.2016.06.086 · Cited by 37
Surgically induced brain injury in rats: The effect of erythropoietin
Matchett, G. A., Hahn, J. M., Obenaus, A., & Zhang, J. H. (2006) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2006.06.003 · Cited by 37
Jia, Z., Xue, R., Ma, S., Xu, J., Guo, S., Li, S., Zhang, E., Wang, J., & Yang, J. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9438-1 · Cited by 37
Phan, V. H. G., Duong, H. S., Le, Q.-G. T., Janarthanan, G., Vijayavenkataraman, S., Nguyen, H.-N. H., Nguyen, B.-P. T., Manivasagan, P., Jang, E., Li, Y., et al. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02160-2 · Cited by 36
“This glycoprotein hormone consists of 165 amino acid residues which are specifically secreted by the peritubular cells of the kidneys [35–37].”
BackgroundGovindappa, P. K., Talukder, M. A. H., Gurjar, A. A., Hegarty, J. P., & Elfar, J. C. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106330 · Cited by 38
Erythropoietin in ophthalmology: A literature review
Aghdam, K. A., Sanjari, M. S., & Falavarjani, K. G. (2016) · Journal of Current Ophthalmology · doi:10.1016/j.joco.2016.01.008 · Cited by 36
Szabadfi, K., Pintér, E., Reglődi, D., & Gabriel, R. (2014) · International review of cytology · doi:10.1016/b978-0-12-800179-0.00001-5 · Cited by 44
Pakravan, M., Esfandiari, H., Hassanpour, K., Razavi, S., & Pakravan, P. (2017) · Current Eye Research · doi:10.1080/02713683.2016.1270328 · Cited by 36
Konstantinopoulos, P. A., Karamouzis, M. V., & Papavassiliou, A. G. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.07.002 · Cited by 34
Valable, S., Francony, G., Bouzat, P., Fevre, M.-C., Mahious, N., Bouët, V., Farion, R., Barbier, E., Lahrech, H., Rémy, C., et al. (2009) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.222 · Cited by 33
“These protein kinases are known to be involved in neuronal death/survival pathways (Subramaniam and Unsicker, 2006) and were then proposed to have a key role in erythropoietin-mediated neuroprotection (Digicaylioglu and Lipton, 2001; Ghezzi and Brines, 2004).”
BackgroundThe Effect of Erythropoietin on Gentamicin‐Induced Auditory Hair Cell Loss
Monge, A., Nagy, I., Bonabi, S., Schmid, S., Gassmann, M., & Bodmer, D. (2006) · The Laryngoscope · doi:10.1097/01.mlg.0000199400.08550.3f · Cited by 33
Shi, M., Flores, B., Li, P., Gillings, N., McMillan, K. L., Ye, J., Huang, L. J.-S., Sidhu, S. S., Zhong, Y.-P., Grompe, M. T., et al. (2017) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00306.2017 · Cited by 33
“The protective effect of EpoR/EPO signaling on ischemia injury has been described in several organs (10, 23, 25, 34, 47, 65, 74, 79, 83, 88, 91).”
BackgroundBarbosa, C., & Romão, L. (2014) · RNA · doi:10.1261/rna.040915.113 · Cited by 35
“…EPO mRNA expression has also been detected in the brain (neurons and glial cells), lung, heart, bonemarrow, spleen, hair follicles, and the reproductive tract (Fandrey and Bunn 1993; Dame et al. 1998; Yasuda et al. 1998; Ghezzi and Brines 2004; Weidemann and Johnson 2009; Hoch et al. 2011).”
BackgroundJang, S. Y. (2018) · Korean Journal of Neurotrauma · doi:10.13004/kjnt.2018.14.1.1 · Cited by 32
Erythropoietin activates the phosphoinositide 3-kinase/Akt pathway in human melanoma cells
Kumar, S., Yu, H., Fong, D., Ács, G., & Xu, X. (2006) · Melanoma Research · doi:10.1097/01.cmr.0000222594.60611.c3 · Cited by 32
Alexander, M. L., Hill, C. A., Rosenkrantz, T. S., & FITCH, R. H. (2012) · Developmental Neuroscience · doi:10.1159/000345645 · Cited by 31
Myocardial Protection by Erythropoietin During Resuscitation from Ventricular Fibrillation
Singh, D. K., Kolarova, J. D., Wang, S., Ayoub, I. M., & Gazmuri, R. J. (2007) · American Journal of Therapeutics · doi:10.1097/01.pap.0000249957.35673.f0 · Cited by 30
Erythropoietin improves spatial learning and memory in streptozotocin model of dementia
Hamidi, G. A., Arabpour, Z., Shabrang, M., Rashidi, B., Alaei, H., Sharifi, M. R., Salami, M., & Reisi, P. (2013) · Pathophysiology · doi:10.1016/j.pathophys.2013.01.001 · Cited by 30
Ding, G., Jiang, Q., Li, L., Zhang, L., Wang, Y., Zhang, Z. G., Lü, M., Panda, S., Li, Q., Ewing, J. R., et al. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22470 · Cited by 31
“EPO reduces neuronal apoptosis (Ghezzi and Brines, 2004; Sirén et al., 2006), and the therapeutic profile of EPO is complex, with antiapoptotic, antioxidant, antiinflammatory, and neurotrophic properties (Sirén et al.”
BackgroundPiloto, N., Teixeira, H. M., Teixeira‐Lemos, E., Parada, B., Garrido, P., Sereno, J., Pinto, R. M. A., Carvalho, L., Costa, E. M., Belo, L., et al. (2009) · Cardiovascular Toxicology · doi:10.1007/s12012-009-9054-2 · Cited by 30
“Therefore, rhEPO alone has promoted a significant increment in serum antioxidant capacity (TAS), together with a reduction in 3-nitrotyrosine content, a marker of peroxynitrite formation, which is in agreement with its action on other pathological circumstances [26–29].”
BackgroundResultGhassemi-Barghi, N., Varshosaz, J., Etebari, M., & Jafarian‐Dehkordi, A. (2016) · Toxicology in Vitro · doi:10.1016/j.tiv.2016.07.001 · Cited by 29
Cervellini, I., Annenkov, A. E., Brenton, T., Chernajovsky, Y., Ghezzi, P., & Mengozzi, M. (2013) · Molecular Medicine · doi:10.2119/molmed.2013.00013 · Cited by 30
Self-citationCervellini, I., Bello, E., Frapolli, R., Porretta‐Serapiglia, C., Oggioni, N., Canta, A., Lombardi, R., Camozzi, F., Roglio, I., Melcangi, R. C., et al. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9127-9 · Cited by 29
“Several downstream signaling pathways in the nervous system including MAPKs, phosphatidylinositol-3-kinase (PI3K), and signal transducers and activators of transcription-5 (STAT-5 (Ghezzi and Brines 2004; Siren et al. 2009) acting through the EPOR are important for EPO neuroprotection.”
BackgroundSelf-citationUse of agents stimulating erythropoiesis in digestive diseases
López, R. M., Aladrén, B. S., & García, F. G. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.4675 · Cited by 32
Zhande, R., & Karsan, A. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00649.2006 · Cited by 29
“The antiapoptotic function of EPO has been the subject of many studies performed in the past few years (20, 24).”
Background3D Bioprinting of Novel Biocompatible Scaffolds for Endothelial Cell Repair
Wu, Y., Heikal, L., Ferns, G. A., Ghezzi, P., Nokhodchi, A., & Maniruzzaman, M. (2019) · Polymers · doi:10.3390/polym11121924 · Cited by 28
“EPO has been shown to be tissue-protective in models of ischaemic, traumatic and inflammatory injury [15].”
BackgroundSelf-citationViruez-Soto, A., López-Dávalos, M. M., Rada‐Barrera, G., Merino‐Luna, A., Molano-Franco, D., Tinoco-Solórzano, A., Zubieta-DeUrioste, N., Zubieta-Calleja, G. R., Arias‐Reyes, C., & Soliz, J. (2021) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2021.103709 · Cited by 28
“In neural pathological contexts, studies in animal models of ischemic stroke and head trauma have shown that EPO is a potent neuroprotective factor that activates anti-apoptotic, anti-inflammatory, anti-cytotoxic, and antioxidant molecular mechanisms (Gassmann et al., 2003; Ghezzi and Brines, 2004).”
Can we improve neurological outcomes in severe traumatic brain injury?
Nichol, A., & Cooper, D. J. (2009) · Injury · doi:10.1016/j.injury.2009.01.002 · Cited by 28
“Study/sub study n EPO sub-type Route Dosing regimen Ehrenreich 2002 40 EPO-b iv 3300 iu/day 3 Corwin 2002# 316 EPO-a sc 40,000 iu week Ehrenreich 2007 5 EPO-a iv 48000 iu/week 3 EPO-a iv 8000 iu/week Ehrenreich 2007 5 EPO-a iv 40000 iu/week Springborg 2007 73 EPO-a iv 500 iu/kg/day Corwin 2007# 793 EPO-a sc 40,000 iu…”
BackgroundInfluentialRole of Erythropoietin in Cerebral Glioma: An Innovative Target in Neuro-Oncology
Torregrossa, F., Aguennouz, M., Torre, D. L., Sfacteria, A., & Grasso, G. (2019) · World Neurosurgery · doi:10.1016/j.wneu.2019.06.221 · Cited by 27
Bench to bedside: A role for erythropoietin in sepsis
Walden, A. P., Young, D., & Sharples, E. J. (2010) · Critical Care · doi:10.1186/cc9049 · Cited by 29
“Animal models of traumatic and compressive peripheral and central nerve injury and models of wound healing show consistent cytoprotective eff ects, with EPO correlating with reduced apoptosis, improved wound healing and reduced infl ammation [11,89].”
BackgroundEffects of the application of erythropoietin on cerebral recovery after cardiac arrest in rats
Popp, E., Vogel, P., Teschendorf, P., & Böttiger, B. W. (2007) · Resuscitation · doi:10.1016/j.resuscitation.2007.01.019 · Cited by 27
Cytoprotective effects of erythropoietin: What about the lung?
Haine, L., Yegen, C.-H., Marchant, D., Richalet, J., Boncoeur, É., & Voituron, N. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111547 · Cited by 26
Ramírez, R., Carracedo, J., Nogueras, S., Buendía, P., Merino, A. M., Cañadillas, S., Rodríguez, M., Tetta, C., Martín‐Malo, A., & Aljama, P. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.09.005 · Cited by 26
Klemm, K., Eipel, C., Cantré, D., Abshagen, K., Menger, M. D., & Vollmar, B. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003924 · Cited by 28
Li, J., Vesey, D. A., Johnson, D. W., & Gobe, G. C. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.12.4975 · Cited by 25
Erythropoietin-induced neuroprotection requires cystine glutamate exchanger activity
Sims, B., Clarke, M., Njah, W., Hopkins, E. S., & Sontheimer, H. W. (2010) · Brain Research · doi:10.1016/j.brainres.2010.01.040 · Cited by 25
“In brain, multiple pathways are involved in Epo-induced neuroprotection including the modulation of antiapoptotic factors (Chong et al., 2007) such as caspases 1, 3, and 8 (Ghezzi and Brines, 2004).”
BackgroundRespiratory plasticity in response to changes in oxygen supply and demand
Bavis, R. W., Powell, F. L., Bradford, A., Hsia, C. C. W., Peltonen, J. E., Soliz, J., Zeis, B., Fergusson, E. K., Fu, Z., Gassmann, M., et al. (2007) · Integrative and Comparative Biology · doi:10.1093/icb/icm070 · Cited by 28
“In fact, many subsequent studies proved that Epo exerts a protective function in several stroke models (Gassmann et al. 2003; Ghezzi and Brines 2004; Marti 2004), against light-induced (but not inherited) retinal degeneration (Grimm et al.”
BackgroundElliot‐Portal, E., Laouafa, S., Arias‐Reyes, C., Janes, T. A., Joseph, V., & Soliz, J. (2018) · SLEEP · doi:10.1093/sleep/zsy072 · Cited by 27
Pharmacokinetic and toxicity study of intravitreal erythropoietin in rabbits
Zhang, J., Wu, Y., Xu, J., Ye, W., Zhang, Y., Weng, H., Shi, W., Xu, G., Luo, L., Dai, W. H., et al. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00885.x · Cited by 26
Yao, S., Soutto, M., & Sriram, S. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21697 · Cited by 29
“The mechanism by which IL-1 and TNFa increase HIF-1a actions is not fully clear and appears to be dependent on the nature of the cell lines and experimental conditions (Ghezzi and Brines, 2004; Dery et al., 2005).”
BackgroundG-CSF activation of AKT is not sufficient to prolong neutrophil survival
Souza, L. R., Silva, E., Calloway, E., Cabrera, C., & McLemore, M. L. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.1211591 · Cited by 26
Hepatic changes of erythropoietin gene expression in a rat model of acute-phase response
Ramadori, P., Sheikh, N., Ahmad, G., Dudás, J., & Ramadori, G. P. (2009) · Liver International · doi:10.1111/j.1478-3231.2009.02131.x · Cited by 24
Effect of erythropoietin on liver regeneration in an experimental model of partial hepatectomy
Gül, M., Cömert, M., Cakmak, G. K., Kertiş, G., Uğurbaş, E., & Öner, M. Ö. (2012) · International Journal of Surgery · doi:10.1016/j.ijsu.2012.11.012 · Cited by 23
Taşdemir, S., Parlakpınar, H., Vardı, N., Kaya, E., & Acet, A. (2011) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2011.01016.x · Cited by 23
Faim2 contributes to neuroprotection by erythropoietin in transient brain ischemia
Komnig, D., Gertz, K. R., Habib, P., Nolte, K. W., Meyer, T., Brockmann, M. A., Endres, M., Rathkolb, B., de Angelis, M. H., Schulz, J. B., et al. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14296 · Cited by 23
“Previous findings that EPO signals through the PI3K/Akt pathway (Ghezzi and Brines 2004) and that Faim2 promoter activity is regulated by Akt (Beier et al.”
BackgroundGuyot, C., Combe, C., Clouzeau‐Girard, H., Moronvalle-Halley, V., & Desmoulière, A. (2007) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-007-0390-y · Cited by 23
“Indeed, EPO has been described to show anti-apoptotic and tissue protective effects [7]; moreover, cultured adult rat cardiomyocytes subjected to hypoxia were prevented from apoptosis by EPO [5].”
BackgroundPark, H., Kong, M. J., Jang, H., Cho, J., Park, E., Lee, I., Frøkiær, J., Nørregaard, R., Park, K. M., & Kwon, T. (2020) · Kidney International · doi:10.1016/j.kint.2020.07.043 · Cited by 23
Artesunate and erythropoietin synergistically improve the outcome of experimental cerebral malaria
Du, Y., Chen, G., Zhang, X., Yu, C., Cao, Y., & Cui, L. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.05.008 · Cited by 23
Shen, Y., Yu, H., Yuan, T., Gu, W., & Wu, Y. (2009) · Neuropathology · doi:10.1111/j.1440-1789.2009.01005.x · Cited by 22
“chemokines followed by leukocyte infiltration and glial activation.(27) IL-1b and TNF-a are two well-characterized pro-inflammatory cytokines in inflammation, which participate in neonatal CNS damage by inducing the production of other inflammatory and cytotoxic mediators, promoting”
BackgroundErythropoietin inhibits apoptosis induced by photodynamic therapy in ovarian cancer cells
Solár, P., Kovaĺ, J., Mikeš, J., Kleban, J., Solárová, Z., Lazúr, J., Hodorová, I., Fedoročko, P., & Sytkowski, A. J. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0483 · Cited by 22
Savino, R., & Ciliberto, G. (2004) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401469 · Cited by 22
Editorial: Neuro-Immune Interactions in Inflammation and Autoimmunity
Terrando, N., & Pavlov, V. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00772 · Cited by 26
Second-generation non-hematopoietic erythropoietin-derived peptide for neuroprotection
Cho, B., Yoo, S., Kim, S. Y., Lee, C., Lee, Y., Lee, S., & Moon, C. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102223 · Cited by 21
The protective effect of darbepoetin alfa on experimental testicular torsion and detorsion injury
Akçora, B., Altuğ, M. E., Kontaş, T., & Atık, E. (2007) · International Journal of Urology · doi:10.1111/j.1442-2042.2007.01844.x · Cited by 24
Plasma Proteins Associated with Chronic Histopathologic Lesions on Kidney Biopsy
Kim, T., Surapaneni, A., Schmidt, I. M., Eadon, M. T., Kalim, S., Srivastava, A., Pálsson, R., Stillman, I. E., Hodgin, J. B., Menon, R., et al. (2024) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000000000358 · Cited by 20
“34 – 39 Furthermore, mice with tubule-speci fi c Epor deletion have more severe AKI and more tubulointerstitial fi brosis after ischemia-reperfusion injury.”
BackgroundMcVicar, C., Colhoun, L. M., Abrahams, J. L., Kitson, C. L., Hamilton, R. W., Medina, R. J., Dash, D. P., Gardiner, T. A., Rudd, P. M., & Stitt, A. W. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011870 · Cited by 20
“Exogenous EPO may also have important benefits in retinal disease and its neuroprotective activity is shown by inhibition of apoptosis following a variety of cellular insults [4,14,15,16,17].”
BackgroundInfluentialZhou, S., Liu, Y., Ya, Z., Hu, J., Liu, D., Chen, H., Li, M., Guo, Y., Fan, L., Li, L., et al. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26833 · Cited by 20
“Second, it functions as an antioxidant and has anti-inflammatory, and anti-apoptosis effects.(45) In our study, we demonstrated that preconditioning with EPO before infusion markedly increased the homing and therapeutic ability of BMSCs, and a single administration of EPO pretreated BMSCs ameliorated renal structure i…”
BackgroundEntezari, M., Flavarjani, Z. K., Ramezani, A., Nikkhah, H., Karimi, S., Moghadam, H. F., Daftarian, N., & Yaseri, M. (2019) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-019-04383-2 · Cited by 20
Otoprotective effects of erythropoietin on Cdh23erl/erl mice
Han, F., Yu, H., Zheng, T., Ma, X., Zhao, X., Li, P., Liu, L., Su, Y., & Zheng, Q. Y. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.01.052 · Cited by 19
“N IH -PA Author M anuscript N IH -PA Author M anuscript acts on non-haemopoietic cells in a cytoprotective manner in damaged tissues and organs (Ghezzi and Brines, 2004).”
BackgroundMengozzi, M., Cervellini, I., Bigini, P., Martone, S., Biondi, A., Pedotti, R., Gallo, B. M., Barbera, S., Mennini, T., Boraso, M., et al. (2008) · Molecular Medicine · doi:10.2119/2008-00086.mengozzi · Cited by 19
Self-citationEffect of quercetin on cell protection via erythropoietin and cell injury of HepG2 cells
Nishimura, K., Matsumoto, R., Yonezawa, Y., & Nakagawa, H. (2017) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2017.10.013 · Cited by 21
Kajitani, K., Thorne, M., Samson, M. L., & Robertson, G. S. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.36 · Cited by 22
Gammella, E., Leuenberger, C., Gassmann, M., & Østergaard, L. (2012) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00112.2012 · Cited by 18
Neuroprotection and endocytosis: erythropoietin receptors in insect nervous systems
Miljus, N., Massih, B., Weis, M. A., Rison, J. V., Bonnas, C., Sillaber, I., Ehrenreich, H., Geurten, B. R. H., & Heinrich, R. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.13967 · Cited by 19
Moon, C., Krawczyk, M., Lakatta, E. G., & Talan, M. I. (2006) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-006-0080-z · Cited by 18
“However, only the anti-apoptotic mechanism of EPO has been convincingly demonstrated, and nearly all known antiapoptotic signaling pathways have been reported to be affected by EPO [6, 24].”
BackgroundDing, S. L. S., Kumar, S. S., Khan, M. S. A., & Mok, P. L. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00190 · Cited by 18
Digkas, E., Chrisafi, S., Passadaki, T., Tsalkidis, A., Hatzimichail, A., Vargemezis, V., & Lialiaris, T. S. (2010) · Chemotherapy · doi:10.1159/000316849 · Cited by 17
Kim, M. S., Seo, Y. K., Park, H. J., Lee, K. H., Lee, K. H., Choi, E. J., Kim, J. K., Chung, H. L., & Kim, W. T. (2010) · Korean Journal of Pediatrics · doi:10.3345/kjp.2010.53.10.898 · Cited by 17
Bone Marrow Endothelial Cells Induce Immature and Mature B Cell Egress in Response to Erythropoietin
Ito, T., Hamazaki, Y., Takaori‐Kondo, A., & Minato, N. (2017) · Cell Structure and Function · doi:10.1247/csf.17018 · Cited by 18
“Erythropoietin receptor is expressed in nonhematopoietic cells, such as brain vascular endothelial cells, cardiac myocytes, neuronal cells, and kidneys, and has cytoprotective functions in such cells (Arcasoy, 2008; Ghezzi and Brines, 2004).”
BackgroundRjiba-Touati, K., Ayed‐Boussema, I., Belarbia, A., Azzebi, A., Achour, A., & Bacha, H. (2011) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2011.08.004 · Cited by 16
“For example, in erythroid cells, rhEPO educed the pro-apoptotic protein BAD, and increased the producion of anti-apoptotic proteins of the Bcl-xL family (Wojchowski t al., 1999; Ghezzi and Brines, 2004).”
BackgroundHempel, C., Hoyer, N., Kildemoes, A. O., Jendresen, C., & Kurtzhals, J. A. L. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00291 · Cited by 16
“EPO has been associated with protection of cells and tissue beyond the hematopoietic lineage (12, 13).”
BackgroundMok, P. L., Cheong, S., Leong, C. F., Chua, K. H., & Ainoon, O. (2011) · Cytotechnology · doi:10.1007/s10616-011-9413-2 · Cited by 16
“While high concentrations of recombinant EPO could be administered intravenously to enable some protein to reach the injured sites, there are also risks of thrombosis and hypertension to be considered (Baskin and Lasker 1990; Ghezzi and Brines 2004; Lieutaud et al. 2008; Loo and Beguin 1999).”
BackgroundNguyen, D. H., Chen, N. G., Zhang, Q., Le, H. T., Aguilar, R. J., Yu, Y., Cappello, J., & Szalay, A. A. (2013) · Molecular Therapy · doi:10.1038/mt.2013.149 · Cited by 16
Erythropoietin promotes functional recovery in a mouse model of postoperative ileus
Elfar, W., Gurjar, A. A., Talukder, M. A. H., Noble, M., Lorenzo, C. D., & Elfar, J. C. (2020) · Neurogastroenterology & Motility · doi:10.1111/nmo.14049 · Cited by 17
Kittur, F. S., Hung, C., Zhu, C., Shajahan, A., Azadi, P., Thomas, M. D., Pearce, J. L., Grünwald‐Gruber, C., Kallolimath, S., & Xie, J. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.04.199 · Cited by 16
Effect of Erythropoietin on Healing of Corneal Epithelial Defects in Rabbits
Livny, E., Livnat, T., Yakimov, M., Masoud, M., Weinberger, D., & Bahar, I. (2013) · Ophthalmic Research · doi:10.1159/000351627 · Cited by 15
Erythropoietin Stimulates GABAergic Maturation in the Mouse Hippocampus
Khalid, K., Frei, J., Aboouf, M. A., Köster-Hegmann, C., Gassmann, M., Fritschy, J., & Gasser, E. M. S. (2021) · eNeuro · doi:10.1523/eneuro.0006-21.2021 · Cited by 16
“In the hippocampus, it inhibits apoptosis associated with glutamate toxicity, and promotes survival and neurogenesis (Doggrell, 2004; Mennini et al., 2006; Hassouna et al., 2016; Zhang et al., 2018).”
Mpekoulis, G., Kalliampakou, K. I., Milona, R. S., Lagou, D., Ioannidis, A., Jahaj, E., Chasapis, C. T., Kefallinos, D., Karakasiliοtis, I., Kotanidou, Α., et al. (2022) · Cells · doi:10.3390/cells12010012 · Cited by 16
Deng, H., Zhang, J., Yoon, T., Song, D., Li, D.-D., & Lin, A. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.11.011 · Cited by 15
“The anti-apoptotic function of Epo has been the subject of many studies performed in the past few years (Abutin et al., 2009; Ghezzi and Brines, 2004).”
BackgroundErythropoietin and the skin: a role for epidermal oxygen sensing?
Paus, R., Bodó, E., Kromminga, A., & JELKMANN, W. E. B. (2009) · BioEssays · doi:10.1002/bies.200800192 · Cited by 16
Yazıhan, N., Ataoğlu, H., Kavas, G. Ö., Akyürek, N., İlçe, B. Y., & Aydm, C. (2008) · Journal of Investigative Surgery · doi:10.1080/08941930802438906 · Cited by 15
Loesch, A., Tang, H., Cotter, M. A., & Cameron, N. E. (2010) · Angiology · doi:10.1177/0003319709360030 · Cited by 17
Impact of acellular hemoglobin‐based oxygen carriers on brain apoptosis in rats
Vandegriff, K. D., Malavalli, A., Lohman, J., Young, M. A., Terraneo, L., Virgili, E., Bianciardi, P., Caretti, A., & Samaja, M. (2014) · Transfusion · doi:10.1111/trf.12643 · Cited by 14
Kittur, F. S., Lin, Y., Arthur, E., Hung, C., Li, P. A., Sane, D. C., & Xie, J. (2019) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2019.01.004 · Cited by 16
Effect of recombinant erythropoietin on ischemia–reperfusion-induced apoptosis in rat liver
Shawky, H. M., Younan, S. M., Rashed, L. A., & Shoukry, H. S. (2011) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-011-0114-2 · Cited by 14
“EPO has been recognized as an antiapoptotic, mitogenic, and tissue-protective pleiotropic cytokine [11].”
Satoh, K., Fukumoto, Y., Nakano, M., Kagaya, Y., & Shimokawa, H. (2011) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318235e7bb · Cited by 15
Temporal and spatial distribution of erythropoietin in transgenic tobacco plants
Conley, A. J., Jevnikar, A. M., Menassa, R., & Brandle, J. E. (2009) · Transgenic Research · doi:10.1007/s11248-009-9306-8 · Cited by 13
“Recently, EPO has also been shown to act as a pleiotropic cytokine with remarkable tissue-protective activities in many models of neuronal, retinal, cardiac, and renal injury (Ghezzi and Brines 2004; Maiese et al. 2005).”
BackgroundHeinrich, R., Günther, V., & Miljus, N. (2017) · Vitamins and hormones · doi:10.1016/bs.vh.2017.02.004 · Cited by 13
Talukder, M. A. H., Lee, J. I., Hegarty, J. P., Gurjar, A. A., O'Brien, M., Karuman, Z., Wandling, G. D., Govindappa, P. K., & Elfar, J. C. (2020) · Muscle & Nerve · doi:10.1002/mus.27121 · Cited by 13
Buitrago‐Molina, L. E., Dywicki, J., Noyan, F., Trippler, M., Pietrek, J., Schlué, J., Manns, M. P., Wedemeyer, H. H., Jaeckel, E., & Hardtke‐Wolenski, M. (2021) · Biomedicines · doi:10.3390/biomedicines9010058 · Cited by 13
“Furthermore, Epo inhibits the apoptosis of erythroid progenitor cells, and is tissue-protective [18,19].”
BackgroundCross-platform transcriptomic profiling of the response to recombinant human erythropoietin
Wang, G., Kitaoka, T., Crawford, A., Mao, Q., Hesketh, A. R., Guppy, F. M., Ash, G. I., Liu, J. J., Gerstein, M., & Pitsiladis, Y. P. (2021) · Scientific Reports · doi:10.1038/s41598-021-00608-9 · Cited by 19
Peptide Derivatives of Erythropoietin in the Treatment of Neuroinflammation and Neurodegeneration
Ercan, İ., Tüfekçi, K. U., Karaca, E., Genç, Ş., & Genç, K. (2018) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2018.01.007 · Cited by 13
Erythropoietin ameliorates chemotherapy‐induced fibrosis of the lungs in a preclinical murine model
Sigounas, G., Salleng, K. J., Mehlhop, P. D., & Sigounas, D. G. (2008) · International Journal of Cancer · doi:10.1002/ijc.23426 · Cited by 14
“The anti-inflammatory property of EPO has been well-documented by other investigators.(25,44) Although there is controversy as to whether EPO exerts a direct or indirect effect on the production of pro-inflammatory proteins, such as TNF-a and IL-1, convincing evidence exists to suggest that EPO may block the activity…”
BackgroundSinclair, S. H., & Schwartz, S. S. (2020) · Vide Leaf, Hyderabad eBooks · doi:10.37247/paendo.1.2020.4 · Cited by 12
Chu, Q., Zhang, J., Wu, Y., Zhang, Y., Xu, G., Li, W., & Xu, G. (2010) · Clinical and Experimental Ophthalmology · doi:10.1111/j.1442-9071.2010.02437.x · Cited by 12
Xie, Z., Chen, F., Wu, X., Zhuang, C.-R., Zhu, J., Wang, J., Ji, H., Wang, Y., & Hua, X. (2012) · Current Eye Research · doi:10.3109/02713683.2011.647225 · Cited by 12
Kandasamy, K., Choudhury, S., Singh, V., Addison, M. P., Darzi, S. A., Kasa, J. K., Thangamalai, R., Dash, J. R., Kumar, T., Sultan, F., et al. (2015) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248415587968 · Cited by 20
“In a randomized study involving critically ill patients, EPO treatment was associated with lower mortality,(27) and it was attributed to cytoprotective, antiapoptotic, and anti-inflammatory effects.(28) Roberta and coworkers(29) demonstrated the beneficial effects of a low dose of recombinant EPO in rodent models of e…”
Background
Metadata
- Authors
- Ghezzi, P., & Brines, M.
- Affiliations
- Mario Negri Institute for Pharmacological Research (IT)
- Oswego Community Hospital (US)
- Corresponding author
- Ghezzi, P
- Venue
- Cell Death & Differentiation
- Published
- 2004-07
- Volume
- 11
- Issue
- S1
- Pages
- S37-S44
- ISSN
- 1350-9047 (ISSN-L)
- 1476-5403
- OpenAlex
- W2121188367
- Cited by
- 327
- References
- 94
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 6 · 2023: 9 · 2022: 11 · 2021: 12 · 2020: 14 · 2019: 11 · 2018: 13 · 2017: 12 · 2016: 9 · 2015: 7 · 2014: 18 · 2013: 15 · 2012: 18
- FWCI
- 2.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Cell Death and Differentiation (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutional Research information system (University of Urbino) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heme Oxygenase-1 and Carbon Monoxide
- Keywords
- erythropoietin, neuroprotection, neuronal apoptosis, signaling pathways, erythroid progenitor cells, tissue protection, bone marrow erythropoiesis
- MeSH terms
- Animals, Anti-Inflammatory Agents, DNA-Binding Proteins, Epithelial Cells, Erythropoietin, Hematopoiesis, Humans, Inflammation, Kidney Tubules, Models, Biological, Neurons, Nuclear Proteins, Transcription Factors, Signal Transduction, Cytokines, Myocardial Ischemia, Apoptosis, Neuroprotective Agents, Cytoprotection, Trauma, Nervous System, Endothelial Cells, Hypoxia-Inducible Factor 1, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.